A Medtronic hypertension procedure that can provide last-resort treatment for a condition that affects nearly half of all U.S ...
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...
Medtronic today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD ...
New data from Medtronic Patient Preference study presented at TCT 2021; Medtronic adds to its clinical leadership for renal denervation with launch of the SPYRAL AFFIRM study DUBLIN and ORLANDO, Fla., ...
Medtronic today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.
The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.
DUBLIN and CHENNAI, India, Sept. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with the Hugo™ ...
MINNEAPOLIS — Seventy-five years ago, Medtronic, the world’s largest medical device company, was born. It was created in a garage in Minneapolis by two men who would go on to invent the pacemaker.
The Robotic Prostatectomy Took Place at Apollo Hospitals, Greams Road, Chennai, India DUBLIN and CHENNAI, India, Sept. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results